🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/06/2007 | 32,96 | 33,45 | 32,63 | 32,79 | -0,64% | 2,49% | 861.800 |
| 31/05/2007 | 32,80 | 33,22 | 32,69 | 33,00 | +0,56% | 1,60% | 1.494.200 |
| 30/05/2007 | 33,16 | 33,50 | 32,76 | 32,81 | -1,87% | 2,23% | 1.528.000 |
| 29/05/2007 | 33,43 | 33,57 | 33,01 | 33,44 | +0,00% | 1,69% | 1.475.400 |
| 25/05/2007 | 33,63 | 33,71 | 33,20 | 33,44 | -0,37% | 1,50% | 1.376.600 |
| 24/05/2007 | 33,63 | 33,66 | 33,28 | 33,56 | -0,71% | 1,14% | 2.323.800 |
| 23/05/2007 | 33,81 | 34,06 | 33,62 | 33,80 | -0,06% | 1,32% | 1.097.400 |
| 22/05/2007 | 33,40 | 34,01 | 33,22 | 33,82 | +0,97% | 2,37% | 1.035.000 |
| 21/05/2007 | 33,79 | 33,81 | 33,38 | 33,50 | -0,40% | 1,27% | 1.097.800 |
| 18/05/2007 | 33,68 | 34,00 | 33,35 | 33,63 | +2,16% | 1,93% | 2.874.200 |
| 17/05/2007 | 33,19 | 33,25 | 32,83 | 32,92 | -0,74% | 1,28% | 1.221.400 |
| 16/05/2007 | 32,58 | 33,22 | 32,35 | 33,17 | +2,60% | 2,67% | 2.214.600 |
| 15/05/2007 | 32,83 | 33,00 | 32,27 | 32,33 | -1,22% | 2,24% | 1.420.800 |
| 14/05/2007 | 32,44 | 32,88 | 32,44 | 32,73 | +0,89% | 1,36% | 2.926.000 |
| 11/05/2007 | 31,75 | 32,73 | 31,63 | 32,44 | +2,25% | 3,46% | 2.540.200 |
| 10/05/2007 | 32,00 | 32,24 | 31,67 | 31,72 | -1,26% | 1,78% | 2.143.000 |
| 09/05/2007 | 31,44 | 32,17 | 30,90 | 32,13 | +2,05% | 4,06% | 3.068.600 |
| 08/05/2007 | 30,52 | 31,59 | 29,85 | 31,48 | +6,21% | 5,70% | 3.896.000 |
| 07/05/2007 | 29,57 | 29,66 | 29,38 | 29,64 | -0,03% | 0,95% | 825.400 |
| 04/05/2007 | 29,70 | 29,70 | 29,42 | 29,65 | -0,08% | 0,96% | 892.600 |
| 03/05/2007 | 29,05 | 29,69 | 28,99 | 29,68 | +2,12% | 2,41% | 1.577.600 |
| 02/05/2007 | 29,09 | 29,27 | 28,65 | 29,06 | +0,19% | 2,11% | 1.587.800 |
| 01/05/2007 | 27,15 | 29,17 | 27,00 | 29,01 | +3,76% | 7,99% | 4.949.800 |
| 30/04/2007 | 28,10 | 28,56 | 27,93 | 27,96 | -0,29% | 2,22% | 2.999.800 |
| 27/04/2007 | 27,87 | 28,06 | 27,73 | 28,04 | -0,11% | 1,20% | 1.055.800 |
| 26/04/2007 | 27,88 | 28,10 | 27,70 | 28,07 | +1,21% | 1,43% | 1.196.600 |
| 25/04/2007 | 27,67 | 27,88 | 27,45 | 27,73 | +0,54% | 1,54% | 892.400 |
| 24/04/2007 | 27,79 | 27,92 | 27,40 | 27,58 | +0,22% | 1,87% | 955.800 |
| 23/04/2007 | 27,42 | 27,85 | 27,42 | 27,52 | +0,86% | 1,57% | 1.312.600 |
| 20/04/2007 | 27,65 | 27,73 | 27,04 | 27,29 | -0,46% | 2,50% | 1.043.800 |